Evidence supporting the use of: Curcuminoid
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Curcuminoids, the active compounds found in turmeric (Curcuma longa), have attracted scientific interest for their potential neuroprotective effects relevant to dementia, particularly Alzheimer's disease. The rationale is based on curcuminoids’ anti-inflammatory, antioxidant, and anti-amyloid properties observed in preclinical (cell and animal) studies. These studies demonstrate that curcuminoids can reduce oxidative stress, inhibit the aggregation of amyloid-beta plaques, and decrease neuroinflammation, all of which are implicated in the pathogenesis of dementia.

However, evidence from human clinical trials is limited and mixed. Systematic reviews and meta-analyses up to 2023 indicate that while some small studies suggest cognitive benefits in individuals with mild cognitive impairment or at risk for dementia, most trials do not show a significant or consistent effect on cognitive outcomes in patients with established dementia. Bioavailability issues remain a significant challenge, as curcumin is poorly absorbed and rapidly metabolized in humans.

Overall, while there is a strong scientific rationale and promising preclinical data, the clinical evidence supporting the use of curcuminoids for dementia is currently insufficient and inconsistent. Therefore, its use can be rated as "scientific" but with only modest supporting evidence (2/5). Further large-scale, well-designed clinical trials are required to determine its efficacy in dementia.

More about Curcuminoid
More about Dementia

Products containing Curcuminoid

We currently have no products on Vitabase that contain this ingredient.